The Form 4 filing, an SEC report of insider stock activity, was filed on October 13, 2026. It lists October 12, 2026, as the date of all four sales by Agarwal Arjun, Oruka Therapeutics' senior vice president of finance. The company's ticker is ORKA.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-12 |
| Date of Latest Transaction | 2026-10-12 |
| Buy/Sell | sell |
| Transaction Count | 4 |
| Shares Transacted | 9,999 |
| Price | $80.60 |
| Total Transaction Value | $805,888.87 |
| Insider | |
| Ticker Symbol | ORKA |
| Company | Oruka Therapeutics, Inc. |
| Insider Name | Agarwal Arjun |
| Insider Title | Senior Vice President, Finance |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 14,219 |
| Position Size Change | 41.29% |
| Filing | |
| Filing Date | 2026-10-13 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales, reported under transaction code S. The reported activity consists of four sales by one insider in a single filing.
What was the average price of the transaction?
The average sale price across the four transactions was $80.60 per share, rounded to cents. Prices for each separate sale were not provided.
How did this transaction affect the insider's holdings?
Agarwal Arjun sold 9,999 shares and reported owning 14,219 shares afterward. The shares sold made up 41.29% of the shares held before the sales.
What's the total transaction value?
The total for all four transactions was $805,888.874. Rounded to cents, that is $805,888.87.
Are there any special circumstances around this transaction?
The filing information points to a Rule 10b5-1 trading plan. These plans set trading instructions in advance. Footnotes and plan terms were not provided, so it is unclear which of the four sales the plan covers. The date the plan was set up and its trading schedule are unknown. The reference alone does not show whether the plan met the rule's requirements.
For research purposes only; not investment advice.